Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD.

(ROG)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
07/16/2019 07/17/2019 07/18/2019 07/19/2019 07/22/2019 Date
266.05(c) 268.65(c) 271.2(c) 264.65(c) 264.7 Last
1 728 037 1 997 700 1 767 599 2 583 116 1 339 653 Volume
+0.68% +0.98% +0.95% -2.42% +0.02% Change
More quotes
Financials (CHF)
Sales 2019 60 696 M
EBIT 2019 22 027 M
Net income 2019 14 090 M
Debt 2019 2 214 M
Yield 2019 3,45%
Sales 2020 61 301 M
EBIT 2020 22 179 M
Net income 2020 14 222 M
Finance 2020 1 984 M
Yield 2020 3,55%
P/E ratio 2019 16,2x
P/E ratio 2020 16,1x
EV / Sales2019 3,76x
EV / Sales2020 3,66x
Capitalization 226 B
More Financials
Company
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists... 
Sector
Pharmaceuticals
Calendar
07/25 | 01:00amEarnings Release
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
01:00aRoche expands the Global Access Program beyond HIV to also include diagnostic..
GL
07/18Novartis raises full-year targets, aims to settle U.S. lawsuit
RE
07/18Novartis raises full-year targets, aims to settle U.S. lawsuit
RE
07/16Abbott to hike production of lower-cost glucose monitors as diabetes soars
RE
07/12EUROPE : Swiss stocks keep a lid on European shares as pharma drag lingers
RE
07/11EUROPE : European shares dip on pharma drag as Fed optimism sizzles out
RE
07/09GENENTECH : Presents a Broad Range of Data for Hemlibra (Emicizumab-kxwh) Demons..
BU
07/09Roche presents a broad range of data for Hemlibra demonstrating continued ben..
GL
07/08European shares dip on Deutsche Bank, fading hopes of sharp Fed cut
RE
07/08SPARK THERAPEUTICS : Roche, Spark push back takeover deadline in $4.3 billion de..
RE
More news
Analyst Recommendations on ROCHE HOLDING LTD.
More recommendations
Sector news : Pharmaceuticals - NEC
12:38pGLAXOSMITHKLINE : ViiV Healthcare Finds Positive Data In HIV Drug Study
DJ
12:04pBAYER : Iberogast Drug Is Safe
DJ
11:22aFDA Approves Multiple Applications for Generic Version of Lyrica
DJ
10:43aALLERGAN : Form 8.3 -
DJ
10:18aMERCK AND : Bayer sells Dr. Scholl's footcare brand to Yellow Wood Partners
RE
More sector news : Pharmaceuticals - NEC
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROCHE HOLDING LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 289,59  CHF
Last Close Price 264,70  CHF
Spread / Highest target 34,5%
Spread / Average Target 9,40%
Spread / Lowest Target -24,4%
EPS Revisions
Managers
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Christoph Franz Chairman
Alan Hippe Chief Financial & Information Technology Officer
John Irving Bell Non-Executive Director
Andreas Oeri Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.8.73%230 263
JOHNSON & JOHNSON0.98%345 980
PFIZER-2.02%237 451
ROCHE HOLDING10.69%230 263
NOVARTIS24.78%216 273
MERCK AND COMPANY6.52%209 550